57230-04-3

Basic information

• Product Name: 3-(BENZYLOXY)-4,5-DIMETHOXYBENZALDEHYDE
• Synonyms: 3-(BENZYLOXY)-4,5-DIMETHOXYBENZALDEHYDE
• CAS NO: 57230-04-3
• Molecular Formula: C₁₆H₁₆O₄
• Molecular Weight: 272.3
• Mol File: 57230-04-3.mol
• Article Data: 9

Chemical Properties

• Melting Point: 48-49 °C
• Boiling Point: 194-195 °C(Press: 0.8 Torr)
• Appearance: /
• Density: 1.164±0.06 g/cm3(Predicted)
• Solubility: DCM
• CAS DataBase Reference: 3-(BENZYLOXY)-4,5-DIMETHOXYBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(BENZYLOXY)-4,5-DIMETHOXYBENZALDEHYDE(57230-04-3)
• EPA Substance Registry System: 3-(BENZYLOXY)-4,5-DIMETHOXYBENZALDEHYDE(57230-04-3)

Safety Data

• Hazardous Substances Data: 57230-04-3(Hazardous Substances Data)

Usage

Description

3-(Benzyloxy)-4,5-dimethoxybenzaldehyde is an organic compound that serves as a crucial intermediate in the synthesis of various pharmaceutical compounds. It is characterized by its benzyloxy and dimethoxy functional groups attached to a benzene ring, with an aldehyde group at the 3-position. 3-(BENZYLOXY)-4,5-DIMETHOXYBENZALDEHYDE plays a significant role in the development of new drugs and therapies.

Uses

Used in Pharmaceutical Industry:
3-(Benzyloxy)-4,5-dimethoxybenzaldehyde is used as an intermediate in the synthesis of metabolites of Trimethoprim (T795615), an antibacterial agent. It is commonly prescribed in conjunction with Sulfametoxazole (S699086) to treat patients afflicted with urinary tract infections. 3-(BENZYLOXY)-4,5-DIMETHOXYBENZALDEHYDE's unique structure allows for the development of effective treatments against bacterial infections, contributing to the overall improvement of public health.

Upstream product

• 51425-83-3 N’-(3-(benzyloxy)-4,5-dimethoxybenzoyl)benzenesulfonohydrazide 
• 29865-90-5 3-hydroxy-4,5-dimethoxybenzaldehyde 
• 100-44-7 benzyl chloride 
• 77-78-1 dimethyl sulfate 
• 100-39-0 benzyl bromide 
• 101289-41-2 3-benzyloxy-4,5-dihydroxybenzoic acid hydrazide 
• 26409-24-5 methyl 3-benzyloxy-4,5-dimethoxybenzoate 
• 79831-86-0 methyl 3-(benzyloxy)-4,5-dihydroxybenzoate 
• 99-24-1 methyl galloate 
• 3934-87-0 5-hydroxyvanillin 
• 2973-76-4 5-bromo-4-hydroxy-3-methoxybenzaldehyde 
• 121-33-5 vanillin 
• 7632-62-4 3-benzyloxy-4,5-dimethoxybenzyl alcohol 

Downstream Products

• 5164-97-6 1-benzyloxy-2,3-dimethoxy-5-[(E)-2-nitrovinyl]benzene 
• 138566-58-2 O-trimethylsilyl 3-benzyloxy-4,5-dimethoxybenzaldehyde cyanohydrin 
• 29865-90-5 3-hydroxy-4,5-dimethoxybenzaldehyde 
• 212116-74-0 (Z)-2,3'-dibenzyloxy-4',5'-dimethoxystilbene 
• 212116-75-1 (E)-2,3'-dibenzyloxy-4',5'-dimethoxystilbene 
• 7632-62-4 3-benzyloxy-4,5-dimethoxybenzyl alcohol 
• 651340-08-8 3-(benzyloxy)-4,5-dimethoxybenzyl bromide 
• 1028306-04-8 4-benzo[1,3]dioxol-5-ylmethyl-3-(3-benzyloxy-4,5-dimethoxy-benzyl)-dihydro-furan-2-one 
• 1025906-30-2 3-(3-benzyloxy-4,5-dimethoxy-benzyl)-4-(4-benzyloxy-3-methoxy-benzyl)-dihydro-furan-2-one 
• 111537-41-8 5,3‘-dihydroxy-6,7,4‘,5‘-tetramethoxyflavone 
• 93092-23-0 3'-benzyloxy-4',5,5',6,7-pentamethoxyflavone 
• 138566-59-3 1-(3-benzyloxy-4,5-dimethoxyphenyl)-4-(4-benzyloxy-3,5-dimethoxyphenyl)-3-methylbutan-1-one 
• 643-60-7 Anhalamin 
• 912957-28-9 Viscolin 

Relevant articles and documents

Isoquinoline Derivatives, Methods of Synthesis and Uses Thereof

Described herein are compounds, pharmaceutical compositions and methods of using these compounds and pharmaceutical compositions for treating and/or preventing conditions such as amyotrophic lateral sclerosis. These compounds and pharmaceutical compositions are also useful as antivirals and antimicrobial agents.

A concise synthesis of viscolin, and its anti-inflammatory effects through the suppression of iNOS, COX-2, ERK phosphorylation and proinflammatory cytokines expressions

In the present report, a concise synthesis of viscolin (1) has been achieved. The anti-inflammatory effect of viscolin was investigated in vitro and in vivo. Viscolin blocked the expression of iNOS and COX-2, and it also inhibited the ERK for the activation of NF-κB in LPS-stimulated RAW 264.7 macrophages. Western blotting and immunohistochemical analysis revealed that viscolin decreased Carr-induced iNOS and COX-2 expressions. These results could help to deduce the anti-inflammatory mechanisms.

Compositions containing aromatic aldehydes and their use in treatments

Disclosed are pharmaceutical and cosmetic compositions containing aromatic aldehyde compounds. Some of the disclosed compositions are useful as topical therapeutics for treating inflammatory dermatologic conditions. Some of the compositions are useful in transdermal and other systemic dose forms for treating other inflammatory conditions in mammals.